(Q37542382)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

1 reference

title

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

attention deficit hyperactivity disorder

2 February 2020

main subject

0 references

0 references

1 reference

adult attention deficit hyperactivity disorder

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Agnes Mészáros

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Pál Czobor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sára Bálint

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sarolta Komlósi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Viktória Simon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

7 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

The International Journal of Neuropsychopharmacology

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1137-1147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Non-stimulant treatments for ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Effects of nicotinic stimulation on cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Non-stimulant medications in the treatment of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Adult psychiatric status of hyperactive boys grown up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Pharmacotherapy for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Consistency of atypical antipsychotic superiority to placebo in recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Pharmacotherapy of adult ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

A meta-analysis of the efficacy of second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Advanced methods in meta-analysis: multivariate approach and meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Cognitive effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

An increased proportional representation of bipolar disorder in younger depressed patients: Analysis of two clinical databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

7 January 2021

A Systematic Review of Modafinil

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

7 January 2021

Attention deficit hyperactivity disorder in childhood among adults with major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

7 January 2021

Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

7 January 2021

The responsiveness of the Hamilton Depression Rating Scale

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

7 January 2021

Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

7 January 2021

Atomoxetine: the first nonstimulant for the management of attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

7 January 2021

Clinical predictors of acute response with olanzapine in psychotic mood disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990198

7 January 2021

10.1017/S1461145709990198

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19580697%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference